Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis

Summary

The purpose of this study is to evaluate the effect of fostamatinib compared to placebo on ambulatory blood pressure in patients with active rheumatoid arthritis who are taking a disease-modifying anti-rheumatic drug (DMARD). The study will last for 57 days.

Timeline

Start

2012-04

Primary completion

2013-01

Completion

2013-01

Outcome

Met primary endpoint

registry FOSTA 100 MG BID vs PLACEBO; p = 0.023; Least squares mean treatment difference 2.93 (95% CI 0.40 to 5.45); ANCOVA NCT01563978 ↗

Drugs

Indications